INTRODUCTION
Inflammatory diseases such as rheumatoid arthritis, atherosclerosis, and psoriasis are triggered by a large number of factors (1) (2) (3) (4) . Triggering is characterized by the increased expressions of pro-inflammatory cytokines such as interleukin-1beta (IL-1β), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and inflammatory mediators such as cyclooxygenase-2 (COX-2), and inducible nitric oxide synthase (iNOS) (5) (6) (7) (8) .
Ribosomal protein S3 (rpS3) is a component of the 40S ribosome subunit. In addition to its role in the translation process, rpS3 is involved in several extra-ribosomal functions such as DNA repair and the oxidative stress signaling pathway (9, 10) . Also, rpS3 is a subunit of nuclear NF-κB complexes, which regulate key genes in inflammation, cell proliferation, cell death, and development (11) .
Protein transduction domains (PTDs) such as Tat and PEP-1 have the ability to deliver various hydrophilic macromolecules, including therapeutic proteins (12, 13) . We have reported that Tat-SOD is efficiently transduced into the mammalian cells and improves the diabetic status of mice in a streptozotocin-induced diabetic model (14) . Additionally, transduction of PEP-1-rpS3 prevents neuronal cell death in an ischemic animal model and protects against ultraviolet (UV) radiation-induced DNA damage (15) .
Levosulpiride, (S)-(-)-5-Aminosulfonyl-N-[(1-ethyl-2-pyrrolidinyl) methyl]-2-methoxybenzamide, is an (-)-enantiomer of sulpiride that exhibits anti-emetic, anti-dyspeptic, anti-psychotic, and anti-depressant activities (16) . Levosulpiride specifically blocks dopamine D2 receptors in the central nervous system (CNS) and gastrointestinal tract (17) . Also, dopaminergic receptors are involved in epidermal barrier homeostasis (18) .
In this study, we investigated whether levosulpiride increases the transduction efficiency of PEP-1-rpS3 proteins in vitro and in vivo, and the influence on the anti-inflammatory effect of PEP-1-rpS3 against 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced skin inflammation. Although the mechanism is not fully understood, the results indicate that levosulpiride may be exploited to enhance the transduction efficiency of therapeutic PTD fusion proteins for a variety of disorders. http://bmbreports.org Cells were pretreated with levosulpiride (250 ng/ml) and then incubated with PEP-1-rpS3 for 1 h. Cell toxicity was induced by TPA (4.0 μg/ml). Cell viability was assessed using a MTT assay and is expressed as a percentage of control without TPA treatment. Each bar represents the mean ± SD obtained from five experiments. C, control; LS, levosulpiride.
Fig. 2.
Transduction of PEP-1-rpS3 into HaCaT cells and mouse skin in the presence of levosulpiride. For transduction of (A) PEP-1-rpS3 and (B) PEP-1-GFP, cells were incubated with various concentrations (0.5-2 μM) of PEP-1 fusion proteins for 1 h. When treated with levosulpiride, cells were pretreated with levosulpiride (250 ng/ml) 1 h prior to treatment with PEP-1 fusion proteins. Transduced PEP-1 fusion proteins were analyzed by Western blotting and band intensity by densitometer. (C) PEP-1-rpS3 (3 μM) was topically applied onto the shaved area of mouse dorsal skin for 60 min. Skin tissues were immunostained with rabbit anti-histidine IgG (1：400) and then stained with biotinylated goat anti-rabbit IgG (1：200). The sections were visualized with 3, 3'-diaminobenzidine and observed microscopically. LS, levosulpiride.
RESULTS
Effect of PEP-1-rpS3 on TPA-induced cell toxicity by co-treatment with levosulpiride
We previously reported that transduced PEP-1-rpS3 can reduce DNA lesions in UV-exposed mouse skin, ameliorate ischemic damage by reducing DNA fragmentation and lipid peroxidation, and decrease expression of various pro-inflammatory cytokines in vitro and in vivo (15, 19 and 20) . To investigate the effects of levosulpiride on cell viability, a MTT-based assay was performed. The structure of levosulpiride is shown in Fig.  1A . The inflammatory inducer TPA (4.0 μg/ml) decreased the viability of HaCaT human keratinocytes by 46%, as compared to the control populations. However, levosulpiride had no effect on cell toxicity induced by TPA. PEP-1-rpS3 increased the viability of HaCaT cells in a concentration-dependent manner, and when coadministered with levosulpiride (250 ng/ml), PEP-1-rpS3 enhanced cell viability, compared to the treatment with PEP-1-rpS3 alone (Fig. 1B) . Collectively, the data supported the notion that levosulpiride might enhance the transduction of PEP-1-rpS3 into HaCaT cells without affecting cellular viability, with PEP-1-rpS3 consequently protecting against TPA-induced cell death.
Effect of levosulpiride on transduction of PEP-1-rpS3 into HaCaT cells and mouse skin
We identified the role of levosulpiride as an enhancer of the transduction of PEP-1-rpS3 into HaCaT human keratinocytes and mouse skin. The intracellular transduction of PEP-1-rpS3 increased in a dose-dependent manner ( Fig. 2A) . Levosulpiride (250 ng/ml) significantly increased the transduction efficiency of PEP-1-rpS3 into HaCaT cells, compared to samples not treated with levosulpiride. In addition, the effect of levosulpiride on the transduction of PEP-1-GFP (as a positive control protein) was examined. Transduction of PEP-1-GFP was consistent with that of PEP-1-rpS3 (Fig. 2B) .
To examine the influence of levosulpiride on the in vivo transduction of PEP-1-rpS3, mouse skin was treated with levosulpiride 1 h prior to addition of PEP-1-rpS3. PEP-1-rpS3 was detected in the dermis as well as the epidermis of the subcutaneous layer, and penetrated more deeply in the dermis of the subcutaneous layer pre-treated with levosulpiride ( Fig. 2C ). These results suggest that levosulpiride enhanced the trans-http://bmbreports.org BMB reports 
Enhancement of in vivo anti-inflammatory activity of PEP-1-rpS3 by levosulpiride
To assess whether the increased transduction of PEP-1-rpS3 into mouse skin resulted in increased suppression of TPA-induced inflammation, inflammation was induced by TPA (1.0 μg). As shown in Fig. 3A and 3B, application of levosulpiride did not significantly reduce TPA-induced ear weight and thickness, while topical application of PEP-1-rpS3 produced a clear reduction in ear weight and thickness. Additionally, PEP-1-rpS3 inhibited TPA-induced edema more significantly in the presence of levosulpiride, as compared with results from the set of mice treated solely with PEP-1-rpS3. The histological results from the control group were similar to those in the PEP-1-rpS3 and levosulpiride co-treated groups (Fig. 3C) . These results provide evidence that levosulpiride significantly improved the inhibition of TPA-induced inflammation by PEP-1-rpS3 in vivo.
Effect of PEP-1-rpS3 on the expression level of inflammatory mediators and cytokines in the presence of levosulpiride
To examine whether the expressions of inflammatory mediators and cytokines in the TPA-induced edema mouse model were modulated by treatment with PEP-1-rpS3 and/or levosulpiride, their levels were determined by Western blot and RT-PCR analysis. As shown in Fig. 4A , exposure to TPA led to a marked increase in the levels of COX-2 and iNOS, while levosulpiride had no influence. Treatment with PEP-1-rpS3 was effective in decreasing the elevated levels of COX-2 and iNOS induced by TPA. However, in the presence of both levosulpiride and PEP-1-rpS3, a more significant down-regulation of these genes was observed. Also, the RT-PCR data showed that http://bmbreports.org the levels of IL-6, IL-1β, and TNF-α increased after treatment with TPA (Fig. 4B) . Treatment with levosulpiride did not result in any change. PEP-1-rpS3 effectively reduced the production of all three cytokines induced by TPA. In addition, the anti-inflammatory activity of PEP-1-rpS3, which inhibited the expression of the pro-inflammatory cytokines, was markedly increased in the presence of levosulpiride. These results provided further support for the suggestion that levosulpiride may have increased the transduction of PEP-1-rpS3 into mouse skin.
DISCUSSION
12-O-Tetradecanoylphorbol-13-acetate (TPA) promotes skin carcinogenesis, which is related to inflammatory responses including the development of edema, hyperplasia, and various diseases, as well as the induction of pro-inflammatory cytokines, generation of reactive oxygen species (ROS), overexpression of COX-2, and inducible nitric oxide synthase (iNOS) (5, 6, 21-23). Since inhibition of the production of these inflammatory mediators may be a new paradigm for preventing a variety of inflammatory diseases, much research has focused on the discovery and application of therapeutic drugs, including the use of proteins. However, there are still a myriad of problems concerning the use of therapeutic proteins as drugs, which include unfavorable pharmacokinetic parameters caused by their large molecular size and charge (24) . Ribosomal protein S3 (rpS3) is involved in the DNA repair process by virtue of its DNA deoxyribophosphodiesterase activity and DNA glycosylase activity (25) . Previously, we reported construction of a PTD fusion protein expression vector of PEP-1-rpS3, and demonstrated the efficient transduction ability of PEP-1-rpS3 in vivo as well as in vitro (19) . Sulpiride is well-known for possessing anti-emetic, anti-dyspeptic, and anti-psychotic attributes (16, 17) . In particular, levosulpiride is the levorotatory enantiomer of sulpiride and a highly selective antagonist of D2 receptors. The present study was undertaken to investigate whether the transduction efficiency and anti-inflammatory activity of PEP-1-rpS3 were modulated by levosulpiride.
Presently, PEP-1-rpS3 improved the viability of HaCaT cells in a concentration-dependent manner (Fig. 1B) . Addition of levosulpiride to TPA-treated cells produced no additional toxicity, while PEP-1-rpS3 enhanced the viability of HaCaT cells in the presence of levosulpiride, compared with the absence of levosulpiride. The observations that the transduction of PEP-1-rpS3 into HaCaT cells and mouse skin was increased in the presence of levosulpiride both in vitro and in vivo (Fig. 2) provide evidence that the presence of levosulpiride somehow increases PEP-1-rpS3 transduction and, consequently, increases cell viability.
A TPA-induced inflammation animal model was utilized to assess the influence of levosulpiride on the anti-inflammatory activity of PEP-1-rpS3. PEP-1-rpS3 inhibited ear swelling and the elevation of pro-inflammatory cytokines and inflammatory mediators ( Fig. 3 and 4) , which are distinct characteristics of inflammation. In the presence of levosulpiride, PEP-1-rpS3-mediated inhibition of inflammation was more profound than in the absence of levosulpiride. The collective data strongly supports the idea that the anti-inflammatory activity of PEP-1-rpS3 is closely associated with the levosulpiride-mediated increased transduction of PEP-1-rpS3.
Maintenance of skin barrier homeostasis is very important because epidermal hyperplasia and inflammation arise from the disruption of the skin barrier or from a dry condition of the skin. Metabotrophic and ionotropic receptors play important roles in maintaining the homeostasis of the skin barrier through the regulation of intracellular cyclic AMP concentration (26) . The dopamine 2-like receptor family is composed of dopaminergic D2, D3, and D4 receptors, and is a class of metabotropic G protein coupled receptors. D2-like receptor agonists accelerate barrier recovery, whereas D2-like receptor antagonists delay recovery, prompting the suggestion that dopaminergic receptors participate in epidermal barrier homeostasis (18) . Although the mechanism of levosulpiride that enhances the transduction of PEP-1-rpS3 is unclear, it is conceivable that the topical treatment of skin with TPA disrupts the skin barrier homeostasis and thereby induces inflammation, and consequently, levosulpiride could delay recovery of the disrupted skin barrier homeostasis. Accordingly, PEP-1-rpS3 could be efficiently transduced into the epidermis of the subcutaneous layer of skin. In further studies, to clearly demonstrate that skin barrier homeostasis is related to the transduction mechanism of PTD proteins, it will be necessary to examine whether agonists of dopaminergic D2 receptors affect the transduction of PTD fusion proteins.
In conclusion, the collective results of this study indicate the potential of levosulpiride as an effective enhancer of the transduction of various PTD-fused therapeutic proteins.
MATERIALS AND METHODS

Materials
Levosulpiride and TPA were purchased from Sigma-Aldrich (St. Louis, MO, USA). Primary antibodies against COX-2, iNOS, and β-actin were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). All other chemicals and reagents, unless otherwise stated, were obtained from Sigma-Aldrich and were of the highest analytical grade available.
Cell culture and cell viability test
HaCaT human keratinocytes were grown in DMEM containing 10% FBS and antibiotics (100 μg/ml streptomycin and 100 U/ml penicillin). Cells were maintained at 37 o C under a humidified atmosphere of 95% air/5% CO2. To assess cell viability, cells were seeded into 6-well plates, and after reaching 70% confluency, the cells were pretreated with levosulpiride (250 ng/ml) for 1 h. After removal of levosulpiride, cells were treated with various concentrations of PEP-1-rpS3 (0.5-2 μΜ) for 1 h, followed by treatment with TPA (4.0 μg/ml) for another 12 h. Cell viability was determined using 3-(4,5-dimethylthiazol-2-yl)-2,5-dipheyltetrazolium bromide (MTT), as previously described (27) .
Transduction of PEP-1-fusion proteins into human keratinocytes
PEP-1-rpS3 and PEP-1-green fluorescent protein (PEP-1-GFP) were purified as previously described (19) . To detect the transduction of PEP-1 fusion proteins into HaCaT cells, the cells were grown to desired confluence in 6-well plates. The cells were pretreated with levosulpiride (250 ng/ml) for 1 h, and then exposed to various concentrations (0.5-2 μΜ) of PEP-1 fusion protein. The cells were then harvested and cell extracts were processed for Western blot analysis.
TPA-induced skin inflammation and histology
Male 6-8 week old ICR mice were purchased from the Hallym University Experimental Animal Center. The animals were housed at a constant temperature (23 o C) and relative humidity (60%) with alternating 12 h cycles of light and dark. They were provided with food and water ad libitum. All animals were treated according to the "Principles of Laboratory Animal Care" (NIH Publication No. 86-23), and handling and experimental protocols were approved by the Hallym Medical Center Institutional Animal Care and Use Committee.
Skin inflammation was induced in the right ear of each mouse (n = 5) by topical application of TPA (1.0 μg), dissolved in 20 μl of acetone, to the inner and outer surfaces of the mouse ears as previously described (21) . Levosulpiride (250 ng/ear) was applied to the same surfaces and PEP-1-rpS3 (3 μM) was topically applied 1 h later. The treatments were repeated for three consecutive days. On the fourth day, ear thicknesses and weights of each group (n = 5) were measured using a digital thickness gauge (Mitutoyo, Tokyo, Japan) with a 5-mm diameter punch. For histological analysis, ear biopsy samples were fixed in 4% paraformaldehyde, embedded in paraffin, sectioned at a thickness of 5 μm, and stained with hematoxylin and eosin. For Western blot analysis, proteins from ear biopsy samples were prepared by vigorous homogenization, followed by centrifugation at 10,000 x g for 10 min.
Reverse transcription-polymerase chain reaction (RT-PCR)
Total RNA from ear biopsy samples was isolated using Trizol reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions. cDNA was synthesized from total RNA (2 μg) using reverse transcriptase (1,000 U) and 0.5 μg/μl of oligo-(dT) primer. The cDNA were PCR-amplified with the following specific primers: IL-6 antisense, 5'-TGGATGGTCTTGG TCCTTAGCC-3'; IL-6 sense, 5'-CAAGAAAGACAAAGCCAGAG TCCTT-3'; IL-1β antisense, 5'-GTGCTGCCTAATGTCCCCTTG AATC-3'; IL-1β sense, 5'-TGCAGAGTTCCCCAACTGGTACAT C-3'; TNF-α antisense, 5'-TGGCACCACTAGTTGGTTGTCTT-3'; TNF-α sense, 5'-AAGTTCCCAAATGGCCTCCC-3'; and β-actin antisense, 5'-GGACAGTGAGGCCAGGATGG-3'; β-actin sense, 5'-AGTGTGACGTTGACATCCGTAAAGA-3'. After PCR was performed, the products were resolved on a 1% agarose gel and visualized with UV light after ethidium bromide staining.
Statistical analysis
Data were expressed as the means ± SD. Comparisons between groups were made with ANOVA, followed by Dunnett's test. A value of P ＜ 0.01 was considered to be statistically significant.
